Bovie Medical Co. (NYSE:BVX) shares fell 3.6% on Tuesday . The stock traded as low as $4.28 and last traded at $4.34, with a volume of 423,614 shares. The stock had previously closed at $4.50.

Several research firms have recently weighed in on BVX. JMP Securities reiterated an “outperform” rating and set a $5.00 price target on shares of Bovie Medical in a research note on Wednesday, August 3rd. Zacks Investment Research upgraded Bovie Medical from a “sell” rating to a “hold” rating in a research note on Tuesday, July 19th.

The stock’s market capitalization is $119.29 million. The firm has a 50-day moving average of $2.40 and a 200-day moving average of $1.94.

In related news, insider John J. Mccarthy III acquired 90,750 shares of the stock in a transaction on Wednesday, August 17th. The stock was acquired at an average price of $3.30 per share, for a total transaction of $299,475.00. Following the completion of the purchase, the insider now owns 115,750 shares of the company’s stock, valued at $381,975. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Bovie Medical Corporation (Bovie) is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.